Delivery Order SPE2DB20D3103-SPE2DB23FN4A2
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Biktarvy 50-200-25 mg tablets, a pharmaceutical product, with a ceiling value of $79,746.22 and an ultimate completion date of April 25, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $12,076.18 firm-fixed-price delivery order is for the supply of Biktarvy 50-200-25 mg tablet, a pharmaceutical product. The contract has an ultimate completion date of December 11, 2023 and was awarded on December 9, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Cencora, Inc. holds...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $127,414.32 firm fixed-price delivery order is for the supply of Biktarvy 50-200-25 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $5,922.68 firm fixed-price delivery order is for the supply of Biktarvy 50-200-25 mg tablets, a specialty pharmaceutical medication. The contract has an ultimate completion date of July 27, 2023 and was awarded on July 26, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $6,177.10 firm fixed-price delivery order is for the supply of the medication Biktarvy, a 50-200-25 mg tablet, and has an ultimate completion date of December 7, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop...
- This federal contract award, valued at $5,393.34, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Biktarvy 50-200-25 mg tablets, a pharmaceutical product, to fulfill the medical supply requirements of the DLA. The contract is a delivery order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $32,377.98 fixed-price delivery order is for the pharmaceutical product Biktarvy 50-200-25 mg Tablet, with a period of performance through March 1, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award, valued at $23,714.66, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Biktarvy 50-200-25 mg tablets. It is a firm-fixed-price delivery order with a completion date of February 6, 2024. The contract was awarded on February 5, 2024, and there was no set-aside designation used. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $32,179.47 firm-fixed-price delivery order is for the supply of Biktarvy 50-200-25 mg tablets. The contract has an ultimate completion date of April 25, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $16,548.17 delivery order contract is for the supply of Biktarvy 50-200-25 mg tablets. The contract is not designated with a set-aside and is likely part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FN4A2Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $93,152.90, is for the delivery of Biktarvy 50-200-25 mg tablets. This is a firm fixed-price delivery order contract with a completion date of May 16, 2023. The award was made under an Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $93.2k | 5/15/23 |